DHA supplementation and pregnancy outcome

This is a current project.

Description

Docosahexaenoic acid (DHA) is a member of the omega-3 fatty acid family; it is found in all cell membranes, and is accumulated in especially large quantities in the retina and brain. Over the past decades, evidence has accumulated in support of the hypothesis that DHA may have an important role in pregnancy health and outcomes as well as in the postnatal development of perceptual and cognitive function in infancy.

This project is based on the possibility that prenatal supplementation may be an especially effective way to affect positive pregnancy and postnatal outcomes.

Project Administration

John Colombo, Principal Investigator

Susan Carlson, Principal Investigator

Project Contact

John Colombo, Ph.D.
Director
Schiefelbusch Institute for Life Span Studies
1000 Sunnyside Avenue
1052 Dole Human Development Center
colombo@ku.edu
785-864-4295 (phone)
785-864-5323 (fax)

Funded by:

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)


Send corrections/comments/questions to lifespan@ku.edu

Share...

The University of Kansas prohibits discrimination on the basis of race, color, ethnicity, religion, sex, national origin, age, ancestry, disability, status as a veteran, sexual orientation, marital status, parental status, gender identity, gender expression and genetic information in the University’s programs and activities. The following person has been designated to handle inquiries regarding the non-discrimination policies: Director of the Office of Institutional Opportunity and Access, IOA@ku.edu, 1246 W. Campus Road, Room 153A, Lawrence, KS, 66045, (785)864-6414, 711 TTY.